Meyka AI API is live for developers.Start building.
Advertisement
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc. (NWBO) Stock Overview

Explore Northwest Biotherapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NWBO●PNK
HealthcareBiotechnology
$0.19
$0.001(0.75%)
U.S. Market opens in 7h 36m
Advertisement

Northwest Biotherapeutics, Inc. (NWBO)

Meyka AI Score

Z

Key Financials

Market Cap314M
P/E Ratio-6.97
EPS (TTM)$-0.03
ROE0.62%
Fundamental Analysis

AI Price Forecasts

1 Month$0.40
3 Months$0.25
1 Year Target$0.05

NWBO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Northwest Biotherapeutics, Inc. (NWBO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.97 and a market capitalization of 314M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.49%
5-Day Change
-4.37%
1-Month Change
-18.14%
3-Month Change
-16.06%
6-Month Change
-18.80%
Year-to-Date (YTD) Change
-15.80%
1-Year Change
-29.58%
3-Year Change
-72.64%
5-Year Change
-87.72%
All-Time (Max) Change
-99.98%

Contact Information

https://www.nwbio.com
240 497 9024
4800 Montgomery Lane, Bethesda, MD, 20814

Company Facts

25 Employees
IPO DateDec 14, 2001
CountryUS
Actively Trading

Frequently Asked Questions